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SUMMARY
Chlamydia trachomatis is an important cause of postpartum endometritis and
neonatal conjunctivitis. However, the prevalence of chlamydial genital infection
varies considerably from one population group to another. A study was thus
conducted to determine the incidence of C trachomatis infection of the cervix in
an unselectedgroup ofwomen attending a Belfast antenatal clinic. One hundred
and six patients were screened for evidence of current cervical infection with
C trachomatis or serological evidence of past infection. C trachomatis was
identified in 2 9%, and there was evidence of past infection in 18 9%. No
significant risk factors were identified from gynaecological, contraceptive or
sexual histories. C trachomatis infection was treated with erythromycin and there
were no perinatal complications ascribed to chlamydia.
INTRODUCTION
Chlamydia trachomatis is a common sexually transmitted pathogen which may
have important implications in pregnancy. It has been proposed as a cause of
premature rupture of the membranes," 2 intrauterine growth retardation and
preterm delivery.3 Following delivery it may cause endometritis in the mother,4
and conjunctivitis and pneumonitis in the neonate.5
As with other sexually transmitted diseases, the incidence of genital chlamydial
infection varies significantly from one geographical area to another, and between
population subgroups within a given area. The reported incidence of
C trachomatis infection of the cervix in antenatal patients ranges from 2-3%
in an unselected group of Dutch women6 to 27% in Baltimore adolescents.7
Relatively few antenatal studies have been performed in the British Isles, and
none had previously been undertaken in Northern Ireland.
The aims of this study were thus to determine the incidence of current
C trachomatis infection of the cervix and the prevalence of past C trachomatis
infection in a Belfast antenatal population, and to see ifeither was associated with
adverse pregnancy outcome or postnatal and neonatal morbidity. We also looked
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for a correlation between aspects of sexual history and evidence of chlamydial
infection to see if there were any indentifiable risk factors.
PATIENTS AND METHODS
The patients studied were 106 women attending for their antenatal booking visit
at Jubilee Maternity Hospital, Belfast, between March and July 1989. A detailed
history was taken, including age, parity, number of spontaneous or therapeutic
abortions, previous contraceptive usage, history of previous sexually transmitted
disease or abnormal cervical cytology, age of first coitus, and number of sexual
partners since first coitus. In addition to routine examination, a speculum examin-
ation was performed and a dacron-tipped swab was rotated in the endocervix.
The swab was then rolled over the centre well of a MicroTrak slide (Syva, UK)
which wasfixed inacetone. Theslides weresent totheregional virology laboratory
wherethedirect fluorescent antibody testwasperformed. This involves overlaying
each slide with fluorescein-labelled monoclonal antibody prior to fluorescent
microscopy ( x 40 objective). The presence of 5 or more chlamydia elementary
bodies was considered as a positive result.
Ten millilitres of blood was also taken from each patient and forwarded to the
regional virology laboratory. The serum was stored at - 20°C prior to being
forwarded in batches to the Institute of Ophthalmology in London, where micro-
immuno-fluorescence was performed to determine IgG and IgM titres to the
D - K serovars of C trachomatis.
Verbal consent was obtained for taking the additional samples required for the
study. Those in whom the MicroTrak slide was positive were treated with a
two-week course of erythromycin 250 mg qid, and their partners were treated
concurrently.
RESULTS
The mean age of the patients was 26 years; 56 were nulliparous and 50 were
parous, with a range of parity from 0-7. A history of previous spontaneous
abortion was given by 13 -2%, and 2 -8% had previously undergone termination
ofpregnancy. With regard to previous contraceptive usage, 62 -3% had used the
oral contraceptive pill and 2-9% an intrauterine contraceptive device (IUCD);
27-4% had used barrier methodsand 25-5% had never used any contraception.
Only 3 patients gave a history of previous sexually transmitted disease, and none
gave a history of abnormal cervical cytology.
The average age atfirst coitus was 19 years, with a range from 14 - 29 years. The
distribution of total number of sexual partners is shown in Table 1.
TABLE I
Lifetime number ofsexual partners in 106 patients
No ofpartners No ofpatients Percent
1 47 44-3
2-5 51 48-1
6-10 6 5-7
>10 2 1-9
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Of the MicroTrak slides submitted, all but two were suitable for fluorescent
microscopy. Chlamydia elementary bodies were identified in only three cases,
representing an incidence of cervical infection of 2 9%. By contrast, 18 9% of
the patients had positive serology, suggesting that they had been infected with
C trachomatis in the past (Table 11). Positive serology was considered to be an
IgG or IgM titre to C trachomatis D - K of > 1/16.
TABLE II
Results of tests for C trachomatis antigen and antibody
No oftests Positive result
Number Percent
MicroTrak 104 3 2 9
Serology IgM 106 2 1*9
IgG 106 19 17 9
IgM or IgG 106 20* 18 9
*One of the two patients with a positive IgM titre had a negative IgG titre.
There was no correlation between positive identification of chlamydia, or positive
serology, and expected risk factors such as young age, previous termination of
pregnancy or IUCD use, history of sexually transmitted disease, age at first coitus
or lifetime number of sexual partners.
All 106 pregnancies resulted in the birth of a live infant and there was only one
case of preterm labour. Five of the neonates developed conjunctivitis prior to
discharge from hospital. Staphylococcus aureus was isolated in three cases, and
cultures were negative in the other two. MicroTrak slides were negative in all five.
Eight patients developed postpartum endometritis, but there was no correlation
between this and evidence of chlamydial infection either in the past or during the
pregnancy.
DISCUSSION
The incidence of current C trachomatis infection of the cervix in this study was
2*9%, which is low in comparison with most other studies in the world literature.
It was notably lower than the 7% infection rate reported in a similar study in
Liverpool,8 but comparable to that of 2
- 5% in a study in Cardiff.9 A strong bias
towards infection in the younger age groups has been noted in other studies.'0 I I
This did not hold true in the present study; the three patients in whom infection
was identified were aged 21, 22 and 35 years. However, the lack of correlation
with demographic factors and aspects of sexual history was not surprising with
such a low detection rate. This highlights the difficulties involved in trying to make
screening more selective in low prevalence areas.
It was perhaps more surprising that there was no correlation between expected
risk factors and serological evidence of past infection. The relative infrequency of
previous termination of pregnancy, IUCD use and previous sexually transmitted
disease may have influenced this, as may the relatively high average age at first
coitus and generally low number of sexual partners. These, we feel, are features
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which may be particular to Northern Ireland due to generally conservative
attitudes, and also because the 1967 Abortion Act does not apply here.
In this study there were few complications of pregnancy and a low incidence of
postnatal and neonatal morbidity. This may have been influenced by antenatal
treatment of the three infected women. However, other workers who performed
studies in which infected mothers were not treated antenatally have also shown
no adverse effect on pregnancy outcome.'1-13 In view of this, and the possibility
ofreinfection, it hasbeen suggested thatantenatal screening should beperformed
between 34 and 38 weeks.14 This should be effective in preventing postnatal and
neonatal complications. However, the neonatal complications are generally mild
and respond promptly to erythromycin. Thus, in such a low prevalence area as
Northern Ireland, and in the absence of identifiable risk factors, the value of
routine antenatal screening for C trachomatis is questionable.
We would like to acknowledge the work of Mrs Dorothy Wyatt who read the MicroTrak slides and
Miss M Weller who prepared the manuscript.
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